Therapy of neurodegenerative diseases using neurotrophic factors: cell biological perspective

References

• Kanazawa I. How do neurons die in neurodegenerative diseases? Trends Mol. Med. 7,339–344 (2001).
   Google Scholar
• Bibel M, Barde Y-A. Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system. Gen. Dev. 14, 2919–2937 (2000).
   Google Scholar
• •Recent review on structure and physiological functions of neurotrophins.
   Google Scholar
• Baloh RH, Enomoto H, Johnson EM, Jr., Milbrandt J. The GDNF family ligands and receptors - implications for neural development. CUIT: Opin. Neurobiol. 10, 103–110 (2000).
   Google Scholar
• Ip NY. The neurotrophins and neuropoietic cytokines: two families of growth factors
   Google Scholar
• Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev 27,1–39 (1998).
   PubMed Web of Science ®Google Scholar
• Dragunow M, MacGibbon GA, Lawlor P et al. Apoptosis, neurotrophic factors and neurodegeneration. Rev Neurosci. 8,223–265 (1997).
   Google Scholar
• Hefti F, Armanini MP, Beck KD et a/. Development of neurotrophic factor therapy for Alzheimer's disease. Ciba Found. Symp. 196,54–63 (1996).
   Google Scholar
• Sendtner M. Neurotrophic factors for experimental treatment of motoneuron disease. Frog. Brain Res. 109,365–371 (1996).
   Google Scholar
• Thoenen H. Treatment of Degenerative Disorders of the Nervous System: From Helpless Descriptive Categorization to Rational Therapeutic Approaches. In: Axonal Regeneration M the Central Nervous System. Ingoglia NA, Murray N (Eds), Dekker M. New York, USA, 675–697 (2000).
   Google Scholar
• Conover JC, Yancopoulos GD. Neurotrophin regulation of the developing nervous system: analyses of knockout mice. Rev Neurosci. 8,13–27 (1997).
   PubMedGoogle Scholar
• Cowan WM. Viktor Hamburger and Rita Levi-Montalcini: The path to the discovery of nerve growth factor. Ann. Rev Neurosci. 24,551–600 (2001).
   PubMed Web of Science ®Google Scholar
• Horger BA, Nishimura MC, Armanini MP et al. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J. Neurosci. 18, 4929–4937 (1998).
   PubMed Web of Science ®Google Scholar
• Hagg T. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp. NeuroL 149,183–192 (1998).
   PubMed Web of Science ®Google Scholar
• Eriksdotter JM, Nordberg A, Amberla K et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord 9,246–257 (1998).
   Google Scholar
• Olson L, Nordberg A, von Holst H et al. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG and verbal episodic memory in an Alzheimer patient (case report). J. Neural Transm. Park. Dis. Dement. Sect. 4,79-95 (1992).
   Google Scholar
• Kordower JH, Palfi S, Chen EY et al. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann. NeuroL 46,419–424 (1999).
   PubMed Web of Science ®Google Scholar
• A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology 52,1427–1433 (1999).
   PubMedGoogle Scholar
• A double-blind placebo-controlled clinical trial of sc. recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. Neurology 46, 1244–1249 (1996).
   Google Scholar
• Miller RG, Petajan JH, Bryan WW et al. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann. NeuroL 39,256–260 (1996).
   PubMed Web of Science ®Google Scholar
• Penn RD, Kroin JS, York MM, Cedarbaum JM. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery 40,94–99 (1997).
   PubMed Web of Science ®Google Scholar
• Ochs G, Penn RD, York M et al. A Phase I- II trial of recombinant methionyl human brain derived neurotrophic factor administered by it. infusion to patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord 1, 201–206 (2000).
   PubMed Web of Science ®Google Scholar
• Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog. NeurobioL 57,451–484 (1999).
   PubMed Web of Science ®Google Scholar
• •Comprehensive comparison of the distribution of neurotrophic factors following intraparenchymal and intraventricular injection in the rat brain.
   Google Scholar
• Anderson KD, Alderson RF, Altar CA et al. Differential distribution of exogenous BDNF, NGF and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors. j Comp. NeuroL 357,296–317 (1995).
   Google Scholar
• Sommerfeld MT, Schweigreiter R, Barde YA, Hoppe E. Downregulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. Biol. Chem. 275,8982–8990 (2000).
   Google Scholar
• Weis C, Marksteiner J, Humpel C. Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert. Neuroscience 102, 129–138 (2001).
   Google Scholar
• Davies AM, Minichiello L, Klein R. Developmental changes in NT3 signalling via TrkA and TrkB in embryonic neurons. EMBOJ 14,4482–4489 (1995).
   Google Scholar
• Andres R, Forgie A, Wyatt S, Chen Q, De Sauvage FJ, Davies AM. Multiple effects of artemin on sympathetic neuron generation, survival and growth. Development 128, 3685–3695 (2001).
   PubMedGoogle Scholar
• Tsui-Pierchala BA, Milbrandt J, Johnson EM, Jr. NGF Utilizes c-Ret via a Novel GFL-Independent, Inter-RTK Signaling Mechanism to Maintain the Trophic Status of Mature Sympathetic Neurons. Neuron 33,261–273 (2002).
   Google Scholar
• Trupp M, Scott R, Whittemore SR, Ibanez CF. Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. j Biol. Chem. 274,20885–20894 (1999).
   PubMedGoogle Scholar
• Elson GCA, LeliCyre E, Guillet C et al. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat. Neurosci. 3, 867–872 (2000).
   PubMed Web of Science ®Google Scholar
• Patel TD, Jackman A, Rice FL, Kucera J, Snider WD. Development of sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron 25,345–357 (2000).
   Google Scholar
• Xu B, Zang K, Ruff NL et al. Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB. Neuron 26,233–245 (2000).
   PubMed Web of Science ®Google Scholar
• Cohen-Cory S, Fraser SE. Effects of brain- derived neurotrophic factor on optic axon branching and remodelling in vivo. Nature 378,192–196 (1995).
   Google Scholar
• McAllister AK. Cellular and molecular mechanisms of dendrite growth. Cereb. Cortex 10,963–973 (2000).
   Google Scholar
• •Recent review on the effects of neurotrophins on dendritic maturation.
   Google Scholar
• Yacoubian T, Lo DC. Truncated and-full- length TrkB receptors regulate distinct modes of dendritic growth. Nat. Neurosci. 3,342–349 (2000).
   Google Scholar
• Conner JM, Darracq MA, Roberts J, Tuszynski MH. Nontropic actions of neurotrophins: Subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation. Proc. Natl Acad. Sci. USA 98, 1941–1946 (2001).
   PubMed Web of Science ®Google Scholar
• Lyons WE, Mamounas LA, Ricaurte GA et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl Acad. Sci. USA 96,15239–15244 (1999).
   PubMed Web of Science ®Google Scholar
• Kernie SG, Liebl DJ, Parada LE BDNF regulates eating behavior and locomotor activity in mice. EMBOJ 19,1290–1300 (2000).
   PubMed Web of Science ®Google Scholar
• Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411,86–89 (2001)
   PubMed Web of Science ®Google Scholar
• •This study implies BDNF in the sensitization to levodopa.
   Google Scholar
• Brodski C, Schnürch H, Dechant G. Neurotrophin-3 promotes the cholinergic differentiation of sympathetic neurons. Proc. Natl Acad. Sci. USA 97,9683–9688 (2000).
   Google Scholar
• Thoenen H. Neurotrophins and activity-dependent plasticity. Prog. Brain Res. 128, 183–191 (2000).
   PubMed Web of Science ®Google Scholar
• Von Bartheld CS, Byers MR, Williams R, Bothwell M. Anterograde transport of neurotrophins and axodendritic transfer in the developing visual system. Nature 379, 830–833 (1996).
   PubMed Web of Science ®Google Scholar
• Kohara K, Kitamura A, Morishima M, Tsumoto T. Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 291, 2419–2423 (2001).
   PubMed Web of Science ®Google Scholar
• Kafitz KW, Rose CR, Thoenen H, Konnerth A. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 401, 918–921 (1999).
   PubMed Web of Science ®Google Scholar
• Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS. Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat. Neurosci. 3, 323–329 (2000).
   Google Scholar
• Pozzo-Miller LD, Gottschalk W, Zhang L et al. Impairments in high-frequency transmission, synaptic vesicle docking and synaptic protein distribution in the hippocampus of BDNF knockout mice. J. Neurosci. 19, 4972–4983 (1999).
   PubMed Web of Science ®Google Scholar
• Alsina B, Vu T, Cohen-Cory S. Visualizing synapse formation in arborizing optic axons in viva dynamics and modulation by BDNF. Nat. Neurosci. 4, 1093–1101 (2001).
   Google Scholar
• Engert F, Bonhoeffer T. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 399, 66–70 (1999).
   PubMed Web of Science ®Google Scholar
• Horch HVV, Kruttgen A, Portbury SD, Katz LC. Destabilization of cortical dendrites and spines by BDNF. Neuron 23, 353–364 (1999).
   PubMed Web of Science ®Google Scholar
• Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl Acad. Sci. USA 92, 8856–8860 (1995).
   PubMed Web of Science ®Google Scholar
• Minichiello L, Korte M, Wolfer D et al. Potential role for TrkB receptors in hippocampus-mediated learning. Neuron 24, 401–414 (1999).
   PubMed Web of Science ®Google Scholar
• Xu B, Gottschalk W, Chow A et al. The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. j Neurosci. 20, 6888–6897 (2000).
   PubMed Web of Science ®Google Scholar
• Kossel AH, Cambridge SB, Wagner U, Bonhoeffer T. A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation. Proc. Natl Acad. Sci. USA 98, 14702–14707 (2001).
   Google Scholar
• Linnarsson S, Bjorklund A, Ernfors P. Learning deficit in BDNF mutant mice. Eur. j Neurosci. 9, 2581–2587 (1997).
   PubMed Web of Science ®Google Scholar
• Schaaf MJ, Workel JO, Lesscher HM, Vreugdenhil E, Oitzl MS, Ron DK. Correlation between hippocampal BDNF mRNA expression and memory performance in senescent rats. Brain Res. 915, 227–233 (2001).
   Google Scholar
• Fischer W, Wictorin K, Bjoerklund A, Williams LR, Varon S, Gage FH. Amelioration of cholinergic neurone atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329, 65–68 (1987).
   PubMed Web of Science ®Google Scholar
• Zuccato C, Ciammola A, Rigamonti D et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493–498 (2001).
   PubMed Web of Science ®Google Scholar
• Majdan M, Lachance C, Gloster A et al. Transgenic mice expressing the intracellular domain of the p75 neurotrophin receptor undergo neuronal apoptosis. j Neurosci. 17, 6988–6998 (1997).
   PubMed Web of Science ®Google Scholar
• Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716–719 (1996).
   Google Scholar
• Friedman WJ. Neurotrophins induce death of hippocampal neurons via the p75 receptor. J. Neurosci. 20, 6340–6346 (2000).
   Google Scholar
• Frade JM, Barde YA. Genetic evidence for cell death mediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 126, 683–690 (1999).
   PubMed Web of Science ®Google Scholar
• Ward NL, Hagg T. p75NGFR andcholinergic neurons in the developing forebrain: a re-examination. Dev. Brain Res. 118,79-91 (1999).
   Google Scholar
• Von Schack D, Casademunt E, Schweigreiter R, Meyer M, Bibel M, Dechant G. Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system. Nat. Neurosci. 4, 977–978 (2001).
   Google Scholar
• Naumann T, Casademunt E, Hollerbach E, Hofmann J, Dechant G, Frotscher M, Barde Y-A. The complete deletion of the neurotrophin receptor p75NTR leads to longlasting increases in the number of basal forebrain cholinergic neurons. J. Neurosci. 22, 2409–2418 (2002).
   Google Scholar
• Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 294, 1945–1948 (2001).
   PubMed Web of Science ®Google Scholar
• Jaaro H, Beck G, Conticello SG, Fainzilber M. Evolving better brains: a need for neurotrophins? Trends Neurosci. 24, 79–85
   Google Scholar
• Tuszynski MH. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons. Cell Transplant. 9, 629–636 (2000).
   PubMed Web of Science ®Google Scholar
• Smith DE, Roberts J, Gage FH, Tuszynski MH. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc. Natl Acad. Sci. USA 96, 10893–10898 (1999).
   PubMed Web of Science ®Google Scholar
• Bachoud-Levi AC, Deglon N, Nguyen JP et al. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTE Hum. Gene Ther. 11, 1723–1729 (2000).
   Google Scholar
• Blesch A, Conner JM, Tuszynski MH. Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression. Gene Ther. 8, 954–960 (2001).
   Google Scholar
• KordowerJH, Emborg ME, Bloch J et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 290, 767–773 (2000).
   Google Scholar
• Froestl W Receptors in neurodegenerative diseases. Pharm. Acta Helv. 74, 247–251 (2000).
   Google Scholar
• Ankeny DP, McTigue DM, Guan Z et al. Pegylated brain-derived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury. Exp. Neurol. 170, 85–100 (2001).
   PubMed Web of Science ®Google Scholar
• Saragovi HU, Gehring K. Development of pharmacological agents for targeting neurotrophins and their receptors. Trends Pharmacol. Sci. 21, 93–98 (2000).
   PubMed Web of Science ®Google Scholar
• Haase G, Kennel P, Pettmann B et al. Gene therapy of murine motor neurone disease using adenoviral vectors for neurotrophic factors. Nat. Med. 3, 429–436 (1997).
   PubMed Web of Science ®Google Scholar
• •Evidence for synergism of NT3 and CNTF in a mouse model of ALS.
   Google Scholar
• Natsume A, Mata M, Goss J et al.Bc1-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-0HDA-induced degeneration. Exp. Neurol. 169, 231–238 (2001).
   Google Scholar
• Nagatsu T, Mogi M, Ichinose H, Togari A. Changes in cytokines and neurotrophins in Parkinson's disease. j Neural Transm. Suppl. 277–290 (2000).
   Google Scholar
• Caldwell MA, He X, Wilkie Net al. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat. Biotechnol. 19, 475–479 (2001).
   Google Scholar
• Pencea V, Bingaman KD, Wiegand SJ, Luskin MB. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus and hypothalamus. j Neurosci. 21, 6706–6717 (2001). Affiliations
   Google Scholar